Currently more than 55 million people live with dementia worldwide, with the number of people living with the disease expected to triple…
Read More
#Aducanumab
Filter By
The verdict is in: it’s a yes from the FDA for the controversial Alzheimer’s drug, after a tricky year for Biogen
The pharmaceutical industry has eagerly awaited the decision from the US Food and Drug Administration (FDA) on the first new…
Read More